{"disease":{"id":"genital-tuberculosis-latent","name":"genital tuberculosis latent"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04528277","title":"Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":1050,"lead_sponsor_name":"Huashan Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}